No abstract available.
Acyclovir* ; Necrosis*

No abstract available.
Acyclovir ; Humans

No abstract available.
Acyclovir* ; Herpes Simplex* ; Simplexvirus*

Herpes zoster caused by herpes varicella-zoster virus (VZV). From January to December 2004, 43 patients with herpes zoster were treated by Acyclovir 1000mg/day for 7 days at Demartology Department, Army Hospital No108. In this study, we found good result in 30.23% of patients, moderate result in 67.44%, poor result in 2,33%. Treatment effectiveness related to stage of disease, age when having diagnosis and age of patients.
Herpes Zoster ; Acyclovir ; Therapeutics

In an immunocompromised patient such as HIV infection, disseminated herpes zoster is a common cutaneous manifestation. It is very important to have clinical suspicion of HIV, whenever a patient presents with cutaneous manifestation of HIV. This is a case of a 32 year old male who came in at for consult at our institution with a chief complaint of fluid filled bumps which started on the left abdominal area progressing to the trunk, upper and lower extremities with associated pricking pain. Patient was diagnosed with disseminated zoster and was given acyclovir with noted complete resolution of lesions. Laboratory tests were requested which revealed that the patient also had concomitant HIV and Hepatitis B. Patient was referred to the Center for Tropical and Travel Medicine for proper management.
HIV ; Hepatitis B ; Acyclovir

Acyclovir is highly selective and relatively non-toxic anti-herpes agent. Thirt-y-seven patients with herpetic keratitis were treated with acyclovir. (23 patients with pure epithelial type, 4 patients with accompanying stromal keratitis, and 10 patients with accompanying keratouveitis). Acyclovir was very effective in 23 patients with pure epithelial herpetic keratitis. All epithelial defects healed in a mean healing time of 6.2 +/- 2.3 days. In 4 patients with stromal keratitis, 3 patients healed within 14 days and 1 patient healed on 27 days. In 10 patients with keratouveitis, 8 patients healed within 14 days, 1 patient healed on 21 days, and 1 patient was not healed even after one month. Four patients developed superficial punctate keratopathy during therapy, but no other serious adverse effects were seen.
Acyclovir* ; Humans ; Keratitis ; Keratitis, Herpetic*

Acyclovir is highly selective and relatively non-toxic anti-herpes agent. Thirt-y-seven patients with herpetic keratitis were treated with acyclovir. (23 patients with pure epithelial type, 4 patients with accompanying stromal keratitis, and 10 patients with accompanying keratouveitis). Acyclovir was very effective in 23 patients with pure epithelial herpetic keratitis. All epithelial defects healed in a mean healing time of 6.2 +/- 2.3 days. In 4 patients with stromal keratitis, 3 patients healed within 14 days and 1 patient healed on 27 days. In 10 patients with keratouveitis, 8 patients healed within 14 days, 1 patient healed on 21 days, and 1 patient was not healed even after one month. Four patients developed superficial punctate keratopathy during therapy, but no other serious adverse effects were seen.
Acyclovir* ; Humans ; Keratitis ; Keratitis, Herpetic*

PURPOSE:To report the use of intravitreal antiviral injections as adjunctive therapy in the managementof two immunocompetent patients with acute retinal necrosis. CASE SUMMARY: We performed two or three intravitreal injections of gancyclovir (2,000 microg/0.05 ml) on two patients (two eyes) with acute retinal necrosis resistant to intravenous acyclovir therapy (1,500 mg/m2/day). Both patients received intravitreal antiviral injections for the treatment of retinitis that progressed despite standard intravenous acyclovir therapy. The retinitis resolved, and visual acuity improved after 18 months of follow-up in both cases. CONCLUSIONS: Intravitreal antiviral injections may be a safe and efficacious adjunctive therapy in the management of patients with acute retinal necrosis resistant to intravenous acyclovir therapy.
Acyclovir ; Antiviral Agents ; Follow-Up Studies ; Ganciclovir ; Humans ; Intravitreal Injections ; Retinal Necrosis Syndrome, Acute ; Retinitis ; Visual Acuity

No abstract available.
Acyclovir ; Chickenpox* ; Child* ; Herpesvirus 3, Human* ; Humans

We had studied in 60 patients with herpes zoster in Friendship Hospital and recognised that: men is 83.33%, women 16.67%, mean age was 65.42 ±7.18 mean duration of viral infection was 5.7 ±2.75 days. The sites most affected were thoracic (45%), cranial (23.4%), lumbar (15%), sacral (8.3%), and others (8.3%). We also used Acyclovir to treat 60 patients with zoster and found that: Acyclovir had good result in 89.47% and the vesibullar lesions with wet, red skin still remained in 10.53% patients. Side effects of Acyclovir were: diarrhea in 8.3%, nausea in 5% and vomiting in 3.3% patients. Acyclovir did not change renal and liver functions.
Herpes Zoster ; Aged ; Therapeutics ; Pharmaceutical Preparations ; Acyclovir